Biotech, Pharma Stocks Surge as IPAB Not Triggered
As noted earlier, biotech and pharmaceutical stocks surged higher mid-day on news the Medicare IPAB cost panel was not triggered this year, pushing it into 2017.
Related Stocks:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Honeywell Aerospace to Join S&P 500 & S&P 100; Others to Join S&P MidCap 400 and S&P SmallCap 600
- Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
- SEC probing popular type of private equity fund as it steps up industry scrutiny - Reuters
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader TalkRelated Entities
Standard & Poor'sSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share